Using ultrasound through transparent skull implants for brain imaging
Official title: Transcranial Ultrasound Via Sonolucent Cranioplasty
Run by Northwell Health · NCT06097845 · Data updated 2026-11-12
This study is testing if using ultrasound through clear skull implants can provide a safer and easier way to take brain images for patients who have had cranial surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Northwell Health Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (New York, New York) |
| Status | Recruiting |
| Started | June 27, 2023 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2029 |
| Registry record updated | September 29, 2026 |
| Trial ID | NCT06097845 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who are undergoing reconstructive sonolucent cranioplasty.
✕Probably not a fit
Patients who are pregnant will not benefit from this study due to exclusion criteria.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the use of transcranial ultrasound via sonolucent cranioplasty to provide a non-invasive imaging alternative for patients undergoing cranial reconstruction. By utilizing transparent polymethyl methacrylate (PMMA) materials, the study aims to overcome the limitations of traditional imaging techniques like CT and MRI, which can be burdensome and invasive. The research will collect real-world evidence on the feasibility and efficacy of this innovative approach compared to standard imaging modalities. The study is observational and open-label, focusing on patients who have already received cranioplasty as part of their treatment.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the risks and costs associated with traditional imaging methods for patients undergoing cranial procedures.
How similar studies have gone: While the technique is novel and limited published data exists, early results have shown promise in using transcranial ultrasound through sonolucent cranial plates.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Provision of signed and dated informed consent form. 2. Stated willingness to comply with all study procedures and availability for the duration of the study. 3. Patients who are undergoing reconstructive sonolucent cranioplasty as standard of care. 4. Male or female, aged ≥ 18. Exclusion Criteria: 1\. Patients who are pregnant
Where it's running
-
Lenox Hill Hospital
New York, New York, United States Recruiting
Study contacts
- Principal investigator: Netanel Ben-Shalom, MD — Lenox Hill Hospital
- Study coordinator: Netanel Ben-Shalom, MD
- Email: nbenshalom@northwell.edu
- Phone: 212-434-3900
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Brain connectome project in adults with brain glioma undergoing surgery
This registry collects MRI data and clinical information from adults with glioma to see how brain networks relate to surgery and recovery.
-
Pain relief during urethral bulking: comparing lidocaine versus saline injections
We’re testing whether injecting lidocaine around the urethra reduces pain more than a saline placebo during urethral bulking for stress urinary incontinence.
-
Increased fruit juice for better exercise ability and lower inflammation
This study will test whether drinking two fruit juice beverages daily for two weeks can influence inflammatory markers and how far people can walk in six minutes.
-
Breast Artery Calcification and Heart Health in Women
This study tests whether a breast artery calcification finding on a mammogram is linked to different cardiovascular markers in women 55–65 who do or do not have BAC.
-
Vagustim taVNS: Testing a sham in adults for immune-related conditions
This small, double-blind study tests whether Vagustim taVNS’s sham method works as a believable placebo in healthy adults.
-
Brain-derived miRNA biomarkers in first-episode psychosis
Researchers will test whether specific brain-derived microRNAs in blood can help identify schizophrenia early and track treatment in people with first-episode psychosis on aripiprazole or risperidone.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.